People on the Move
Model N
David Bonnette, CEO of Lanyon, has joined the Board of revenue management firm Model N.
The company provides financial services to life science customers, including Novo Nordisk, Bristol-Myers Squibb and Johnson & Johnson.
Bonnette will join the Board of Directors effective August 29, replacing Jay Larson who is resigning. Before joining software company Lanyon, Bonnette was CEO of BigMachines for three years, establishing the company in the Configure, Price and Quote (CPQ) market and acquiring Oracle.
Model N says it helps pharma companies “maximize their revenue and reduce revenue compliance risk by managing every dollar that impacts their top line” – encompassing contracting, pricing, incentives, and rebates.
